NT 10-K 1 v02392.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING Commission File Number 0-28666 --------- Cusip Number 024600 --------- (Check One): |_| Form 10-K and Form 10-KSB |_| Form 11-K |_| Form 20-F |_| Form 10-QSB |_| Form N-SAR For period ended December 31, 2003. ------------------ Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein. If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A ----- PART I REGISTRANT INFORMATION Full name of registrant American Bio Media Corporation Address of principal executive office (street and number) 122 Smith Road City, state and zip code Kinderhook, NY 12106 PART II RULES 12B-25(B) AND (C) If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |_| (b) The subject annual report on Form 10-KSB will be filed on or before the 15th calendar day following the prescribed due date; and (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. PART III NARRATIVE State below in reasonable detail the reasons why the Form 10-KSB could not be filed within the prescribed time period. (Attach extra sheets if needed.) The Registrant's internal accounting staff has encountered delays in finalizing the Registrant's financial statements on a timely basis due to delays in receiving information from third parties. As a result, the Form 10-KSB for the period ended December 31, 2003 has not been completed and accordingly this notification is being filed. The registrant expects to file its Form 10-KSB on or before April 14, 2004. PART IV OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification: Keith E. Palmer, Chief Financial Officer (518) 758-8158 -------------------------------------------------------------------------- (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, please identity report(s). Yes No (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes No SIGNATURE AMERICAN BIO MEDICA CORPORATION (Name of Registrant as Specified in Charter) Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized. Date: March 30, 2004 By: /s/ Edmund M. Jaskiewicz -------------------------------- Edmund M. Jaskiewicz, President